10-Q: Mag Magna Corp Reports Increased Revenue but Widening Losses in Q3 2025
Quarterly Report (Form 10-Q)
Mag Magna Corp's Q3 2025 shows revenue growth driven by new API services, but net losses also increased due to higher operating expenses.
Summary
- Mag Magna Corp's Q3 2025 report reveals increased revenue compared to Q3 2024, driven by the introduction of API services.
- Total revenue for the three months ended January 31, 2025, was $22,294, compared to $4,200 for the same period in 2024.
- For the nine months ended January 31, 2025, total revenue reached $43,628, up from $5,600 in the corresponding period of 2024.
- However, operating expenses also increased significantly, leading to a net loss of $4,670 for the three months ended January 31, 2025, compared to a net loss of $2,078 in 2024.
- The net loss for the nine months ended January 31, 2025, was $29,730, compared to $15,163 for the same period in 2024.
- The company's accumulated deficit stood at $98,500 as of January 31, 2025.
- The company's disclosure controls and procedures were not effective as of January 31, 2025.
- The company is focused on providing consulting services and API access related to poultry farming, particularly antibiotic-free methods.
- The company relies on related party loans to fund its operations, with $136,587 owed to the director as of January 31, 2025.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative. While revenue increased, losses also widened, and the company's future is uncertain due to its reliance on related party loans and the need to raise additional capital. The ineffective disclosure controls are also a concern.
Positives
- Revenue increased significantly due to the introduction of API services, with total revenue for the three months ended January 31, 2025, reaching $22,294 compared to $4,200 for the same period in 2024.
- The company has introduced the Poultry Wellness Guide API, an AI-powered tool for diagnosing and managing chicken diseases, which is generating revenue through subscription plans.
- The company is focused on a niche market of antibiotic-free poultry farming, which could attract customers seeking sustainable practices.
Negatives
- The company's net loss widened to $4,670 for the three months ended January 31, 2025, compared to $2,078 for the same period in 2024.
- Operating expenses increased significantly, reaching $26,964 for the three months ended January 31, 2025, due to higher spending on consulting, marketing, SEO, and server expenses.
- The company has an accumulated deficit of $98,500 as of January 31, 2025.
- The company's disclosure controls and procedures were deemed not effective as of January 31, 2025.
Risks
- The company's ability to continue as a going concern is dependent on generating profitable operations or obtaining necessary financing.
- The company relies heavily on related party loans, which may not be sustainable in the long term.
- The company's disclosure controls and procedures were deemed not effective as of January 31, 2025.
- The company faces competition in the poultry farming consulting and technology space.
Future Outlook
The company intends to finance operating costs over the next twelve months with existing cash, sales proceeds, and related party loans, but there are no assurances that such additional funding will be achieved.
Industry Context
The company operates in the niche market of providing consulting and technology solutions for antibiotic-free poultry farming, which aligns with the growing consumer demand for sustainable and ethical food production practices.
Comparison to Industry Standards
- It is difficult to compare Mag Magna Corp directly to industry standards due to its specific focus on antibiotic-free poultry farming and its early stage of development.
- Larger agricultural consulting firms like Cargill and Nutreco offer broader services but may not have the same level of specialization in this niche.
- Technology companies like Agritech offer farm management software, but Mag Magna Corp's API focuses specifically on poultry wellness.
- The company's revenue and losses are relatively small compared to established players in the agricultural sector.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Independent Director | Tomasz Anczok | 2025-02-21 |
Related Party Transactions
- As of January 31, 2025, the director of the Company, Oleg Bilinski, advanced $136,587 to the Company.
- During the nine months ended January 31, 2025, Oleg Bilinski advanced to the Company $85,347 for the Company's operating expenses and $54,129 was repaid to the Director.
- This loan is for up to $160,000, unsecured, interest-free, with no fixed payment term, for working capital purposes.
Stakeholder Impact
- Shareholders face increased risk due to the company's widening losses and reliance on related party loans.
- Employees (primarily the President) are impacted by the company's financial performance and ability to continue operations.
- Customers (poultry farmers) may benefit from the company's consulting services and API, but the company's long-term viability could affect service availability.
- The company's creditors (including the director providing the loan) face increased risk due to the company's financial difficulties.
Key Dates
| Date | Description |
|---|---|
| 2021-09-20 | Mag Magna Corp was incorporated. |
| 2022-11-15 | Patent License and Assignment Agreement signed with Ipax LLC. |
| 2023-10-23 | Company received notice of effectiveness from the Securities Exchange Commission. |
| 2024-02-27 | Company entered into Application Programming Interface (API) Development Agreement. |
| 2024-06 | Mag Magna Corp introduced the Poultry Wellness Guide API on website and began selling Subscription Plans for API services. |
| 2025-01-31 | End of the quarterly period for this report. |
| 2025-02-21 | Tomasz Anczok appointed as Independent Director of the Company. |
| 2025-02-25 | Company's Current Report on Form 8-K filed with the Securities and Exchange Commission regarding Mr. Anczok's background. |
| 2025-03-14 | Latest practicable date for shares outstanding. |
| 2025-03-17 | Date of report signature. |
| 2025-04-30 | Company's fiscal year-end. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.